Hrtx stock analysis
Web9 apr. 2024 · 2 analysts have issued twelve-month price targets for Heron Therapeutics' stock. Their HRTX share price forecasts range from $5.50 to $12.00. On average, they expect the company's share price to reach $8.40 in the next twelve months. This … WebTickers, Articles and Keywords: Tickers. Articles
Hrtx stock analysis
Did you know?
Web14 apr. 2024 · In the meantime, 0 analyst(s) believe the stock as Underweight and 5 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is Underweight. The stock’s technical analysis shows that the PEG ratio is about 0, with the price of APE ... Web14 apr. 2024 · The stock is rated as a Hold by 0 analyst(s), 2 recommend it as a Buy and 0 called the MVST stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is …
WebPrice target 8.08R USD +5.36 +197.18% The 6 analysts offering 1 year price forecasts for Heron Therapeutics, Inc. have a max estimate of 10.00 and a min estimate of 5.50. … Web14 apr. 2024 · The stock is rated as a Hold by 2 analyst(s), 3 recommend it as a Buy and 0 called the API stock Overweight. In the meantime, 0 analyst(s) believe the stock as Underweight and 0 think it is a Sell. Thus, investors eager to increase their holdings of the company’s stock will have an opportunity to do so as the average rating for the stock is ...
Web12 apr. 2024 · A high-level overview of Heron Therapeutics, Inc. (HRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebCompany Overview Heron Therapeutics (HRTX ~$17.6) is a small-cap pharmaceutical company (~$1.6B market cap) focusing on two main areas: Chemotherapy-induced nausea and vomiting through their CINV franchise and Post-operative pain through HTX-011 and HTX-034. CINVANTI & SUSTOL are FDA-approved antiemetic treatments that delay …
Web18 uur geleden · Discover historical prices for HRTX stock on Yahoo Finance. View daily, weekly or monthly format back to when Heron Therapeutics, Inc. stock was issued.
Web14 apr. 2024 · The stock is rated as a Hold by 2 analyst(s), 3 recommend it as a Buy and 0 called the API stock Overweight. In the meantime, 0 analyst(s) believe the stock as … high heart rate while gamingWebHeron Therapeutics, Inc. (HRTX) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 2.6800 -0.0400 (-1.47%) At close: December 9 04:00PM EST … high heat 2022 자막WebHRTX stock forecasts by analyst. All Analysts Top Analysts. All All Strong Buy Buy Hold Sell Strong Sell. All Strong Buy Buy Hold Sell Strong Sell. Analyst / Firm Rating Action … high heart rate while resting sickWebProvides key financial indicators of Heron Therapeutics (HRTX), including historical and latest data and analysis. You can query by quarterly, mid-term, and annual reports, and compare historical data easily. high heart rate while showeringWeb12 apr. 2024 · According to analysts, Heron Therapeutics's stock has a predicted upside of 182.01% based on their 12-month price targets. What analysts cover Heron … high heart rate with no other symptomsWebWhile our focus is on highly shorted stock we don’t miss an opportunities . AVCT was mentioned on Aug 24th by one of our member. HRTX has Institutional ownership of … high heart rate while sickWeb13 apr. 2024 · Investor's Guide to Banking Reports: The Four Most Important Details to Look For high heart rate while standing